The pharmacological exploration of GLUT5 regulation and fructose metabolism is crucial for identifying dietary interventions and therapeutic strategies to mitigate metabolic diseases associated with fructose intake (Shi et al. 2021). This evidence concerns the gene SLC2A5 and metabolic disease.